Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment

Luis Alberto Henríquez-Hernández,A. Valenciano,Palmira Foro-Arnalot,Maria Jesus Alvarez-Cubero,Jose Manuel Cozar,José Francisco Suárez-Novo,Manel Castells-Esteve,Pablo Fernández-Gonzalo,Belén De-Paula-Carranza,Montse Ferrer,Ferran Guedea,Gemma Sancho Pardo,Jordi Craven-Bartle,Mariá José Ortiz Gordillo,Patricia Cabrera-Roldán,Estefanía Herrera-Ramos,Carlos Rodríguez-Gallego,P.C. Lara

Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment

2015

Luis Alberto Henríquez-Hernández
A. Valenciano
Palmira Foro-Arnalot
Maria Jesus Alvarez-Cubero
Jose Manuel Cozar
José Francisco Suárez-Novo
Manel Castells-Esteve
Pablo Fernández-Gonzalo
Belén De-Paula-Carranza
Montse Ferrer
Ferran Guedea
Gemma Sancho Pardo
Jordi Craven-Bartle
Mariá José Ortiz Gordillo
Patricia Cabrera-Roldán
Estefanía Herrera-Ramos
Carlos Rodríguez-Gallego
P.C. Lara

This work was subsidized by the grant from the Instituto de Salud Carlos III (Ministerio de Economia y Competitividad from Spain), ID: PI12/01867. Almudena Valenciano has a grant from the Instituto Canario de Investigacion del Cancer (ICIC).

Keywords:

Genetics
Cancer
5 Alpha-Reductase Inhibitor
Prostate cancer
Cancer research
Reductase
Alpha (ethology)
Endocrinology
Internal medicine
Steroid
Biology
3-Oxo-5-alpha-Steroid 4-Dehydrogenase
5 alpha reductase

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations